TDAC and ProLogium Progressing Towards Merger with SEC Filing of F-4#USA#New_York#SEC_Filing#Translational_Development#ProLogium
TDAC and ProLogium Progressing Towards Merger with SEC Filing of F-4
Translational Development Acquisition Company reports ProLogium's F-4 filing with the SEC, a key step towards their merger. Insights shared on future prospects.
third-news.com
July 6, 2026 at 1:57 PM
TDAC and ProLogium Progressing Towards Merger with SEC Filing of F-4#USA#New_York#SEC_Filing#Translational_Development#ProLogium
Translational Development Acquisition Company Reports Successful Shareholder Vote and Fund Retention#United_States#New_York#Translational_Development#ProLogium#SPAC
Translational Development Acquisition Company Reports Successful Shareholder Vote and Fund Retention
TDAC's recent shareholder vote yielded impressive results, retaining over $156 million while celebrating a merger with ProLogium in the battery tech sector.
third-news.com
June 22, 2026 at 11:12 AM
Translational Development Acquisition Company Reports Successful Shareholder Vote and Fund Retention#United_States#New_York#Translational_Development#ProLogium#SPAC
Translational Development Acquisition Corp. Initiates Separate Trading of Class A Ordinary Shares and Warrants#United_States#New_York#NASDAQ#Translational_Development#TDACU
Translational Development Acquisition Corp. Initiates Separate Trading of Class A Ordinary Shares and Warrants
Translational Development Acquisition Corp. has announced that its Class A ordinary shares and warrants are now available for separate trading on Nasdaq.
third-news.com
February 14, 2025 at 9:15 PM
Translational Development Acquisition Corp. Initiates Separate Trading of Class A Ordinary Shares and Warrants#United_States#New_York#NASDAQ#Translational_Development#TDACU
Translational Development Acquisition Corp. Completes $172.5 Million IPO with Full Over-Allotment Option Exercised#United_States#New_York#NASDAQ#IPO#Translational_Development
Translational Development Acquisition Corp. Completes $172.5 Million IPO with Full Over-Allotment Option Exercised
Translational Development Acquisition Corp. successfully closes its IPO, raising $172.5 million. This milestone marks a significant step in their business endeavors.
third-news.com
December 24, 2024 at 5:31 PM
Translational Development Acquisition Corp. Completes $172.5 Million IPO with Full Over-Allotment Option Exercised#United_States#New_York#NASDAQ#IPO#Translational_Development
Translational Development Acquisition Corp. Launches $150 Million IPO on Nasdaq#United_States#New_York#NASDAQ#Translational_Development#TDACU
Translational Development Acquisition Corp. Launches $150 Million IPO on Nasdaq
Translational Development Acquisition Corp. has priced its initial public offering at $150 million. The units will begin trading on Nasdaq today under the symbol TDACU.
third-news.com
December 23, 2024 at 3:54 PM
Translational Development Acquisition Corp. Launches $150 Million IPO on Nasdaq#United_States#New_York#NASDAQ#Translational_Development#TDACU